Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer.

Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer. Cancer Metastasis Rev. 2002; 21(2):159-66.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.